INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2017

A review indicates Berberis vulgaris and berberine can cause dose-dependent toxic effects, requiring caution in pregnancy and with CYP-metabolized drugs.

This review evaluated the toxicity of Berberis vulgaris and its active constituent berberine across acute, sub-acute, sub-chronic, and chronic states, as well as in clinical studies and in vitro/in vivo models. Toxicity depended on the route and duration of administration. B. vulgaris and berberine could induce GI upset and ulceration, immunotoxicity, phototoxicity, neurotoxicity, cardiotoxicity, and jaundice in a dose-dependent manner. Caution is warranted in pregnancy, neonates, G6PD deficiency, and when co-administering with drugs metabolized by CYP enzymes.

Study type
Narrative review
Who was studied
Human clinical studies and animal/in vitro models
What was measured
Toxicological effects including acute, chronic, organ, and developmental toxicity

THE PAPER

Toxicology effects of Berberis vulgaris (barberry) and its active constituent, berberine: a review.

Rad SZK, Rameshrad M, Hosseinzadeh H. Iran J Basic Med Sci, 2017.

PubMed 28656087 ↗DOI 10.22038/ijbms.2017.8676 ↗

Heart & arteriesGut & microbiomeBrain & moodFood safety & contaminantsOther health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.